Multiple Assemblies exist for SMTL entry 5kos
Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor; X-RAY DIFFRACTION 2.41 Å

	SMTL ID 5kos.1 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose; 2-~{tert}-butyl-4-(3-methoxypropylamino)-~{N}-(2-methylpropyl)-~{N}-[(3~{S},5~{R})-5-morpholin-4-ylcarbonylpiperidin-3-yl]pyrimidine-5-carboxamide; DIMETHYL SULFOXIDE; DI(HYDROXYETHYL)ETHER Polypeptides Renin Oligo-state monomer
	SMTL ID 5kos.2 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose; 2-~{tert}-butyl-4-(3-methoxypropylamino)-~{N}-(2-methylpropyl)-~{N}-[(3~{S},5~{R})-5-morpholin-4-ylcarbonylpiperidin-3-yl]pyrimidine-5-carboxamide; DI(HYDROXYETHYL)ETHER; DIMETHYL SULFOXIDE Polypeptides Renin Oligo-state monomer
	SMTL ID 5kos.3 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose; 2-~{tert}-butyl-4-(3-methoxypropylamino)-~{N}-(2-methylpropyl)-~{N}-[(3~{S},5~{R})-5-morpholin-4-ylcarbonylpiperidin-3-yl]pyrimidine-5-carboxamide; DIMETHYL SULFOXIDE; DI(HYDROXYETHYL)ETHER Polypeptides Renin Oligo-state homo-hexamer